Stay updated on Vicriviroc and Pembrolizumab in MSS CRC Clinical Trial

Sign up to get notified when there's something new on the Vicriviroc and Pembrolizumab in MSS CRC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Vicriviroc and Pembrolizumab in MSS CRC Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Revision: v3.4.2 has been added. The previous funding-status notice and Revision: v3.4.1 have been removed.
    Difference
    0.4%
    Check dated 2026-02-11T12:27:07.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Added a government funding lapse notice. Updated the site to revision v3.4.1, replacing v3.4.0.
    Difference
    0.4%
    Check dated 2026-02-04T06:50:50.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Glossary visibility was added and footer metadata was updated to include 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0', with capitalization changes in related labels.
    Difference
    0.2%
    Check dated 2026-01-28T04:49:11.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4. This is a minor version update with no impact on study content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T01:36:26.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Added a dedicated Locations section with regional site listings (Arizona, California, Florida, Tennessee, Texas, Alberta, and Quebec) and replaced the previous location blocks. The HHS Vulnerability Disclosure link was removed in this update.
    Difference
    0.8%
    Check dated 2025-12-23T10:37:31.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    Revision: v3.3.2 was implemented, replacing the previous v3.3.1. This is a minor maintenance update that does not modify any study details, eligibility criteria, or results displayed on the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-12-01T17:20:27.000Z thumbnail image

Stay in the know with updates to Vicriviroc and Pembrolizumab in MSS CRC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Vicriviroc and Pembrolizumab in MSS CRC Clinical Trial page.